These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16690466)

  • 1. Development of a macroprolactinoma in association with hormone replacement therapy in a perimenopausal woman with presumed idiopathic hyperprolactinemia.
    Orrego JJ; Bair J
    Endocr Pract; 2006; 12(2):174-8. PubMed ID: 16690466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy.
    Christin-Maître S; Delemer B; Touraine P; Young J
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):106-12. PubMed ID: 17540335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia: pathophysiology and management.
    Verhelst J; Abs R
    Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia.
    Colao A; Sarno AD; Cappabianca P; Briganti F; Pivonello R; Somma CD; Faggiano A; Biondi B; Lombardi G
    Eur J Endocrinol; 2003 Mar; 148(3):325-31. PubMed ID: 12611613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
    Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
    N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinaemia.
    Patel SS; Bamigboye V
    J Obstet Gynaecol; 2007 Jul; 27(5):455-9. PubMed ID: 17701788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug treatment of hyperprolactinemia.
    Chanson P; Borson-Chazot F; Chabre O; Estour B
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):113-7. PubMed ID: 17532288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactorrhea in a 14-year-old girl.
    Panamonta O; Pakawut N
    J Med Assoc Thai; 2006 Aug; 89(8):1304-7. PubMed ID: 17048445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging.
    Kawaguchi T; Ogawa Y; Tominaga T
    BMC Res Notes; 2014 Aug; 7():555. PubMed ID: 25142896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
    Sabuncu T; Arikan E; Tasan E; Hatemi H
    Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Macroadenoma of the pituitary gland with moderate hyperprolactinaemia].
    Harms E; Siggelkow H; Buchfelder M; Saeger W; Hüfner M
    Dtsch Med Wochenschr; 2003 Mar; 128(13):667-70. PubMed ID: 12660899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
    Barber TM; Kenkre J; Garnett C; Scott RV; Byrne JV; Wass JA
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):819-24. PubMed ID: 21645021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases.
    Eren E; Yapıcı Ş; Çakır ED; Ceylan LA; Sağlam H; Tarım Ö
    J Clin Res Pediatr Endocrinol; 2011; 3(2):65-9. PubMed ID: 21750634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster headache and macroprolactinoma: Case report of a rare, but potential important causality.
    Andereggen L; Mono ML; Kellner-Weldon F; Christ E
    J Clin Neurosci; 2017 Jun; 40():62-64. PubMed ID: 28209309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolactinoma].
    Glezer A; Bronstein MD
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):118-23. PubMed ID: 24830588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
    Balabolkin MI; Gerasimov GA; Liubimov AV
    Akush Ginekol (Mosk); 1990 Feb; (2):54-7. PubMed ID: 2339765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.